Published in BMJ on April 08, 1989
Strategies for prevention of osteoporosis and hip fracture. BMJ (1991) 3.78
A prospective study of alcohol consumption and bone mineral density. BMJ (1993) 1.99
A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int (2001) 1.75
Medical risks for women who drink alcohol. J Gen Intern Med (1998) 1.39
Bone status of Indian women from a low-income group and its relationship to the nutritional status. Osteoporos Int (2005) 1.27
Alcohol use disorders in primary care: do gender-specific differences exist? J Gen Intern Med (2002) 1.25
Cigarette smoking and bone mineral density in older men and women. Am J Public Health (1993) 1.19
Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. J Clin Invest (2000) 1.15
The impact of clothing style on bone mineral density among women in Turkey. Rheumatol Int (2007) 1.08
Bone density in relation to alcohol intake among men and women in the United States. Osteoporos Int (2006) 1.06
Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? Osteoporos Int (2008) 1.06
Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest (1992) 1.03
Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study. Ann Rheum Dis (1994) 1.01
Bone mineral density in coeliac disease. Gut (1994) 0.95
Oral contraceptive treatment inhibits the normal acquisition of bone mineral in skeletally immature young adult female monkeys. Osteoporos Int (1997) 0.93
Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review. Br J Sports Med (2006) 0.90
Bone mineral density in the femoral neck increases after hip resurfacing: a cohort with five-year follow-up. Int Orthop (2010) 0.89
High bone mineral density among perimenopausal women. Osteoporos Int (2005) 0.89
Bone mineral density in relation to medical and lifestyle risk factors for osteoporosis in premenopausal, menopausal and postmenopausal women in general practice. Br J Gen Pract (1995) 0.86
Determinants of forearm bone density in premenopausal women: a study in one general practice. Br J Gen Pract (1991) 0.85
Calcium supplementation of the diet. BMJ (1989) 0.84
Dietary calcium, sex hormones, and bone mineral density in men. BMJ (1990) 0.83
Role of oestrogen in the development of osteoporosis. Calcif Tissue Int (1991) 0.82
Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. European Vertebral Osteoporosis Study Group. Osteoporos Int (1997) 0.81
Peak bone mass and osteoporosis prevention. Osteoporos Int (1993) 0.81
Factors related to risk of osteoporosis in 50-year-old women. Calcif Tissue Int (1991) 0.80
Influence of body parameters on female peak bone mass and bone loss. Osteoporos Int (1993) 0.78
Osteoporosis and atherosclerosis: a post-mortem MDCT study of an elderly cohort. Eur Radiol (2013) 0.78
Racial difference in the correlates of bone mineral content/density and age at peak among reproductive-aged women. Osteoporos Int (2009) 0.78
Bone mineral density among elderly patients with chronic obstructive pulmonary disease patients in India. Niger Med J (2013) 0.77
Bone mineral density in postmenopausal women as determined by prior oral contraceptive use. Am J Public Health (1993) 0.77
Calcium requirements for optimal skeletal health in women. Calcif Tissue Int (1991) 0.77
Predictors of bone mineral density testing among older women on Medicare. Osteoporos Int (2016) 0.76
Association between Lumbar Bone Mineral Density and Carotid Intima-Media Thickness in Korean Adults: a Cross-sectional Study of Healthy Twin Study. J Korean Med Sci (2017) 0.75
Comparison of vertebral and femoral bone mineral density in adult females. J Phys Ther Sci (2016) 0.75
Meta-analysis of cigarette smoking, bone mineral density, and risk of hip fracture. Three studies were omitted from meta-analysis. BMJ (1998) 0.75
Influence of arthritis and non-arthritis related factors on areal bone mineral density (BMDa) in women with longstanding inflammatory polyarthritis: a primary care based inception cohort. BMC Musculoskelet Disord (2010) 0.75
Osteoporosis--an opportunity to prevent being missed. Postgrad Med J (1991) 0.75
Use of a risk factor and dietary calcium questionnaire in predicting bone density and subsequent bone loss at the menopause. Ann Rheum Dis (1992) 0.75
Osteoporosis: whose problem is it? Ann Rheum Dis (1992) 0.75
Study of Different Involutive Changes in Bone Mineral Density Measured in Ward's Triangle and Trabecular Volume Measured in Iliac Crest in Relation to Age. West Indian Med J (2014) 0.75
The clinical problems of women currently referred to a specialist menopause clinic. J R Soc Med (1993) 0.75
Late prevention of hip fractures with hormone replacement therapy. Osteoporos Int (1996) 0.75
Risk factors for bone loss in healthy postmenopausal women. Osteoporos Int (1993) 0.75
Predicting the effects of estrogen replacement therapy on lumbar bone mineral density in oophorectomized women: analysis of a 10-year longitudinal study. Osteoporos Int (2003) 0.75
Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet (1976) 4.24
Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92
Prediction of rapid bone loss in postmenopausal women. Lancet (1987) 2.76
Osteoporosis of the slender smoker. Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity. Arch Intern Med (1976) 2.41
Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med (1982) 2.40
Osteoporosis and the risk of hip fracture. Am J Epidemiol (1986) 2.35
Genetic factors in determining bone mass. J Clin Invest (1973) 2.35
Evidence for two distinct syndromes of involutional osteoporosis. Am J Med (1983) 2.17
Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest (1986) 2.01
Bone mineral content of the lumbar spine in normal and osteoporotic women: cross-sectional and longitudinal studies. Clin Sci (Lond) (1982) 1.75
Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest (1982) 1.48
Interaction of calcium nutrition and physical activity on bone mass in young women. J Bone Miner Res (1988) 1.37
Total bone calcium in normal women: effect of age and menopause status. J Bone Miner Res (1987) 1.25
Dietary calcium intake and rates of bone loss in women. J Clin Invest (1987) 1.17
Spine and femur density using dual-photon absorptiometry in US white women. Bone Miner (1987) 1.15
Identification of alcohol abuse: thoracic fractures on routine chest X-rays as indicators of alcoholism. Alcohol Clin Exp Res (1980) 1.07
Deranged bone mineral metabolism in chronic alcoholism. Metabolism (1987) 0.96
Effect of alcohol ingestion on bone and mineral metabolism in rats. Am J Physiol (1980) 0.93
Different trends of age-related diminution of bone mineral content in the lumbar spine, femoral neck, and femoral shaft in women. Calcif Tissue Int (1988) 0.90
Alcohol-related skeletal disorders. Ann N Y Acad Sci (1975) 0.90
Regional and total skeletal measurements in the early postmenopause. J Clin Invest (1987) 0.89
Effects of age and menopause on vertebral bone density. Bone Miner (1987) 0.89
Evidence of a toxic effect of ethanol on bone in rats. Alcohol Clin Exp Res (1982) 0.85
Menopausal bone loss and estrogen replacement. Isr J Med Sci (1976) 0.82
Body fat distribution, rather than overall adiposity, influences serum lipids and lipoproteins in healthy men independently of age. Am J Med (1995) 2.31
Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr (1992) 2.23
Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet (1990) 2.00
Analgesia in the acute abdomen. Ann R Coll Surg Engl (1986) 1.80
Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial. Fertil Steril (1995) 1.41
The peritrophic matrix of hematophagous insects. Arch Insect Biochem Physiol (2001) 1.31
Preoperative 6-minute walk test adds prognostic information to Euroscore in patients undergoing aortic valve replacement. Heart (2009) 1.27
Effect of degenerative spinal and aortic calcification on bone density measurements in post-menopausal women: links between osteoporosis and cardiovascular disease? Eur J Clin Invest (1994) 1.24
The Anopheles gambiae adult midgut peritrophic matrix proteome. Insect Biochem Mol Biol (2008) 1.21
Pulmonary metastasectomy in colorectal cancer: time for a trial. Eur J Surg Oncol (2009) 1.10
Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial. Lancet (2001) 1.10
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med (1990) 1.08
Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss. Osteoporos Int (1994) 1.06
Prenatal diagnosis in Treacher Collins syndrome using combined linkage analysis and ultrasound imaging. J Med Genet (1996) 1.01
Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Am J Obstet Gynecol (1992) 1.00
Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism (1993) 0.98
Oestrogen deficiency and oestradiol implants. BMJ (1989) 0.96
Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis. Calcif Tissue Int (1996) 0.95
Dietary intake of calcium and postmenopausal bone loss. BMJ (1988) 0.92
Induction of mosquitocidal activity in mice immunized with Anopheles gambiae midgut cDNA. Infect Immun (2003) 0.86
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Contraception (1995) 0.84
A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis. Health Technol Assess (2002) 0.84
DXA longitudinal quality control: a comparison of inbuilt quality assurance, visual inspection, multi-rule Shewhart charts and Cusum analysis. Osteoporos Int (1997) 0.80
A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis. Horm Res (1989) 0.79
Lipid and carbohydrate metabolism in premenopausal women given subdermal estradiol implants. Horm Metab Res (1991) 0.79
Oral versus transdermal hormone replacement therapy. Int J Fertil Menopausal Stud (1993) 0.78
Relationships between insulin metabolism, serum lipid profile, body fat distribution and blood pressure in healthy men. Atherosclerosis (1995) 0.77
Insulin resistance syndrome in postmenopausal women with cardiological syndrome X. Br Heart J (1995) 0.77
17beta-estradiol (1 mg/day) continuously combined with dydrogesterone (5, 10 or 20 mg/day) increases bone mineral density in postmenopausal women. Maturitas (2001) 0.77
Postmenopausal bone loss: does HRT always work? Int J Fertil Menopausal Stud (1993) 0.76
Changes in body composition with danazol therapy. Fertil Steril (1991) 0.76
Effect of hormone replacement therapy on fractures and height loss. Am J Med (2001) 0.75
Measuring body fat. Am J Med (1996) 0.75
Bone mineral response to brief exercise test. BMJ (1989) 0.75
Oestrogen replacement after oophorectomy. BMJ (1992) 0.75
Prolonged endometrial stimulation associated with oestradiol implants. BMJ (1990) 0.75
Bone density over two centuries. Lancet (1993) 0.75
Danazol induces resistance to both insulin and glucagon in young women. Clin Sci (Lond) (1992) 0.75
A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis. Fertil Steril (1993) 0.75
Bone density and endometriosis. Fertil Steril (1994) 0.75
Immediate and associated complications of hysterectomy for benign disease. Aust N Z J Obstet Gynaecol (2002) 0.75
Use of a (proposed) standard protocol to validate Terumo TSCD-II connections between dissimilar blood bag tubing. Vox Sang (2006) 0.75
Work-related health advice in primary care. Occup Med (Lond) (2011) 0.75
The effects of oral desogestrel and estradiol continuous combined hormone replacement therapy on serum lipids and body composition in postmenopausal women. Basic Life Sci (1993) 0.75